These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
147 related items for PubMed ID: 33720390
21. Successful treatment with i.v. immunoglobulin and rituximab for bronchiolitis obliterans associated with paraneoplastic pemphigus. Kaibuchi-Ando K, Sugiura K, Muro Y, Takahashi Y, Kojima S, Ishii N, Hashimoto T, Akiyama M. J Dermatol; 2020 Oct; 47(10):e368-e370. PubMed ID: 32656784 [No Abstract] [Full Text] [Related]
24. Clinical images: Castleman disease and paraneoplastic pemphigus. Kop EN, MacKenzie MA. CMAJ; 2010 Jan 12; 182(1):61. PubMed ID: 19884299 [No Abstract] [Full Text] [Related]
25. Paraneoplastic pemphigus with clinical features of erosive lichen planus associated with Castleman's tumor. Jansen T, Plewig G, Anhalt GJ. Dermatology; 1995 Jan 12; 190(3):245-50. PubMed ID: 7599391 [Abstract] [Full Text] [Related]
26. Paraneoplastic pemphigus associated with CD20-positive follicular non-Hodgkin's lymphoma treated with rituximab: a third case resistant to rituximab therapy. Hoque SR, Black MM, Cliff S. Clin Exp Dermatol; 2007 Mar 12; 32(2):172-5. PubMed ID: 17342796 [Abstract] [Full Text] [Related]
30. Paraneoplastic pemphigus associated with follicular dendritic cell sarcoma arising from Castleman's tumor. Lee IJ, Kim SC, Kim HS, Bang D, Yang WI, Jung WH, Chi HS. J Am Acad Dermatol; 1999 Feb 12; 40(2 Pt 2):294-7. PubMed ID: 10025851 [Abstract] [Full Text] [Related]
31. Paraneoplastic pemphigus in children and adolescents. Mimouni D, Anhalt GJ, Lazarova Z, Aho S, Kazerounian S, Kouba DJ, Mascaro JM, Nousari HC. Br J Dermatol; 2002 Oct 12; 147(4):725-32. PubMed ID: 12366419 [Abstract] [Full Text] [Related]
33. Fatal paraneoplastic pemphigus after removal of Castleman's disease in a child. Daneshpazhooh M, Moeineddin F, Kiani A, Naraghi ZS, Firooz A, Akhyani M, Chams-Davatchi C. Pediatr Dermatol; 2012 Oct 12; 29(5):656-7. PubMed ID: 22276661 [Abstract] [Full Text] [Related]
35. Localized mucosal involvement and severe pulmonary involvement in a young patient with paraneoplastic pemphigus associated with Castleman's tumour. Kim SC, Chang SN, Lee IJ, Park SD, Jeong ET, Lee CW, Ahn CM, Anhalt GJ. Br J Dermatol; 1998 Apr 12; 138(4):667-71. PubMed ID: 9640377 [Abstract] [Full Text] [Related]
37. A Systematic Review of Patients with Mucocutaneous and Respiratory Complications in Paraneoplastic Autoimmune Multiorgan Syndrome: Castleman's Disease is the Predominant Malignancy. Lee J, Bloom R, Amber KT. Lung; 2015 Aug 12; 193(4):593-6. PubMed ID: 25903794 [Abstract] [Full Text] [Related]
38. Anti-desmoglein antibody-negative paraneoplastic pemphigus successfully treated with rituximab. Kanwar AJ, Vinay K, Varma S, Koga H, Ishii N, Hashimoto T. Int J Dermatol; 2015 Aug 12; 54(5):576-9. PubMed ID: 24738571 [No Abstract] [Full Text] [Related]
39. A case of paraneoplastic pemphigus associated with other iatrogenic immunodeficiency-associated lymphoproliferative disorders. Sasaki H, Fujishima C, Hioki C, Yoshida H, Watanabe M, Murata T, Koga H, Ishii N, Kudo H. J Dermatol; 2022 May 12; 49(5):e165-e166. PubMed ID: 34989428 [No Abstract] [Full Text] [Related]
40. Successful treatment of paraneoplastic pemphigus in follicular NHL with rituximab: report of a case and review of treatment for paraneoplastic pemphigus in NHL and CLL. Heizmann M, Itin P, Wernli M, Borradori L, Bargetzi MJ. Am J Hematol; 2001 Feb 12; 66(2):142-4. PubMed ID: 11421295 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]